Skip to content

Urologic complication of hysterectomy in morbid placenta accreta after hydrodisection

Urologic complication in morbid adherent placenta spectrum hysterectomy after hydrodisection

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160130026260N3
Enrollment
69
Registered
2022-03-08
Start date
2022-03-16
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placenta accrete spectrum refers to the range of pathologic adherence of the placenta including placenta increta , percreta and accrete can cause maternal morbidity and mortality because of severe hemorrhage. Placenta accreta

Interventions

Intervention 1: Intervention group: The intervention group is women who underwent bladder hydrodisection with diluted epinephrine 1 in 10,000 with normal saline 0.9 injection in a bladder filled with

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Pregnant women with aged between 20-45 years Gestational aged between 12 and 40 weeks All cases had histology-confirmed placenta accrete spectrum

Exclusion criteria

Exclusion criteria: Patient with focal accreta

Design outcomes

Primary

MeasureTime frame
Bladder injury. Timepoint: during operation. Method of measurement: Methylene blue test.;Ureter injury. Timepoint: during operation. Method of measurement: Intraoperative clinical examination.

Secondary

MeasureTime frame
Determination of bladder hydrodisection role in reducing blood loss during surgery. Timepoint: During surgery. Method of measurement: Minutes.;Determination of bladder hydrodisection role in reducing blood loss during surgery. Timepoint: During surgery. Method of measurement: Cc of blood lost.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShaghayegh Moradi Alamdarloo

Shiraz University of Medical Sciences

shaghayeghmoradi84@gmail.com+98 71 3233 2365

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026